92 related articles for article (PubMed ID: 29061792)
1. Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
Anticancer Res; 2017 Nov; 37(11):6119-6123. PubMed ID: 29061792
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction.
Okui T; Shimo T; Fukazawa T; Kurio N; Hassan NM; Honami T; Takaoka M; Naomoto Y; Sasaki A
Mol Cancer Ther; 2010 Nov; 9(11):2960-9. PubMed ID: 20858724
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.
Okui T; Shimo T; Hassan NM; Fukazawa T; Kurio N; Takaoka M; Naomoto Y; Sasaki A
Anticancer Res; 2011 Apr; 31(4):1197-204. PubMed ID: 21508365
[TBL] [Abstract][Full Text] [Related]
5. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
6. Sonic hedgehog signaling promotes growth of oral squamous cell carcinoma cells associated with bone destruction.
Honami T; Shimo T; Okui T; Kurio N; Hassan NM; Iwamoto M; Sasaki A
Oral Oncol; 2012 Jan; 48(1):49-55. PubMed ID: 21945071
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 14 regulates cell proliferation and apoptosis in oral squamous cell carcinoma.
Chen X; Wu J; Chen Y; Ye D; Lei H; Xu H; Yang L; Wu Y; Gu W
Int J Biochem Cell Biol; 2016 Oct; 79():350-359. PubMed ID: 27592452
[TBL] [Abstract][Full Text] [Related]
8. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin Receptor 3 Distribution in Human Oral Squamous Cell Carcinoma.
Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Nagatsuka H; Sasaki A
Anticancer Res; 2016 Dec; 36(12):6335-6341. PubMed ID: 27919954
[TBL] [Abstract][Full Text] [Related]
10. Activation of Toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells in vitro and in vivo.
Luo Q; Hu S; Yan M; Sun Z; Chen W; Chen F
Int J Biochem Cell Biol; 2012 Aug; 44(8):1266-75. PubMed ID: 22568929
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models.
Yee PS; Zainal NS; Gan CP; Lee BKB; Mun KS; Abraham MT; Ismail SM; Abdul Rahman ZA; Patel V; Cheong SC
Target Oncol; 2019 Apr; 14(2):223-235. PubMed ID: 30806895
[TBL] [Abstract][Full Text] [Related]
13. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
14. Expression of Neurokinin B Receptor in the Gingival Squamous Cell Carcinoma Bone Microenvironment.
Yoshida S; Shimo T; Takabatake K; Murase Y; Obata K; Okui T; Kunisada Y; Ibaragi S; Nagatsuka H; Sasaki A
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34200131
[TBL] [Abstract][Full Text] [Related]
15. The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma.
Li HX; Fu XJ; Yang K; Chen D; Tang H; Zhao Q
Oncotarget; 2016 Apr; 7(15):20574-83. PubMed ID: 26943040
[TBL] [Abstract][Full Text] [Related]
16. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
17. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
Sarau HM; Griswold DE; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Webb EF; Martin LD; Legos JJ; Whitmore RG; Barone FC; Medhurst AD; Luttmann MA; Giardina GA; Hay DW
J Pharmacol Exp Ther; 2000 Oct; 295(1):373-81. PubMed ID: 10992004
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin B activates the formation and bone resorption activity of rat osteoclasts.
Ichiki T; Kuroishi KN; Gunjigake KK; Kobayashi S; Goto T
Neuropeptides; 2011 Jun; 45(3):239-44. PubMed ID: 21514667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
